About CVDEHN Priorities for an EU Cardiovascular Health Plan

EHN’s PRIORITIES for an EU CARDIOVASCULAR HEALTH PLAN

The Burden of Cardiovascular Disease in Europe


CVD causes 1 in 3 deaths in the EU — many of them premature.
CVD hits vulnerable and marginalised communities the hardest.
Over 60 million people in Europe live with cardiovascular disease.
CVD costs the EU €282 billion every year.

80% of premature CVD deaths are preventable

EHN calls on EU institutions to adopt a comprehensive European Cardiovascular Health plan built on three pillars:
Empower Patients
Strengthen Research & Innovation

Effective, equitable prevention can save millions of lives and reduce long-term costs.

Key EU-level actions should include:

Ensure early risk detection through systematic screening for hypertension, cholesterol, diabetes, and atrial fibrillation in primary care

Improving access to affordable, healthy, plant-based diets

Allow people to grow up and live in smoke-free environments by including all tobacco products, nicotine products, and vapes while revising EU tobacco legislation

Develop policies that reduce alcohol consumption in the EU

Strengthen air pollution legislation in the EU

Promote physical activity in urban and local areas

Living with CVD should not mean living with stigma or reduced quality of life.

We urge EU and Member States to:

Protect individuals with CVD from discrimination in employment and insurance policies, enshrining equal treatment as a legal and social norm.

Ensure meaningful patient involvement in health policy, system design, and research.

Expand access to comprehensive, inclusive rehabilitation, with specific support for young patients, including mental health, education, and career guidance.

Modern, well-funded research is essential to fight CVD and tackle inequalities in care.

The EU should:

Promote innovation-friendly regulations to accelerate access to lifesaving diagnostics and therapies.

Increase investment in CVD research with a focus on prevention, diagnosis, and treatment.

Address persistent gaps by prioritising underrepresented populations, particularly women, children, and socioeconomically disadvantaged groups.

Support research into sex-specific symptoms, hormonal impacts, and paediatric CVD.

Health Equity – A Horizontal Priority


Every pillar above must address health inequalities. CVD disproportionately affects those in lower socioeconomic groups, and any EU-level strategy must aim to reduce disparities in exposure, access, and outcomes across the Union.

Time to Act

EHN calls on EU policymakers to deliver a truly all-encompassing European Cardiovascular Health Plan, building on existing tools and aligned with EU competences in public health, internal market, environment, research, and social policy.

The time for fragmented action is over.

The time for a unified, strategic EU response is now.